Amp Capital Investors LTD Amgen Inc Transaction History

Amp Capital Investors LTD

$0
Q4 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $35.2 Million - $40.3 Million	-177,054 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $5.85 Million - $6.86 Million	-27,580 Reduced 13.48%	177,054 $37.7 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $2.33 Million - $2.58 Million	-9,972 Reduced 4.65%	204,634 $49.9 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $1.14 Million - $1.32 Million	-5,119 Reduced 2.33%	214,606 $53.4 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $1.93 Million - $2.29 Million	-8,897 Reduced 3.89%	219,725 $49.9 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $3.73 Million - $4.15 Million	-15,889 Reduced 6.5%	228,622 $56.8 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $5.26 Million - $6.45 Million	-26,572 Reduced 9.8%	244,511 $56.6 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $553,462 - $734,042	-3,037 Reduced 1.11%	271,083 $56.5 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $7.83 Million - $10.1 Million	-41,359 Reduced 13.11%	274,120 $65.9 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $3.95 Million - $4.74 Million	-22,714 Reduced 6.72%	315,479 $61.5 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $4.59 Million - $5.37 Million	27,506 Added 8.85%	338,193 $62.2 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $2.7 Million - $3.04 Million	-14,910 Reduced 4.58%	310,687 $58.3 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $6.93 Million - $8.09 Million	38,865 Added 13.55%	325,597 $62.1 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $1.66 Million - $1.87 Million	-8,963 Reduced 3.03%	286,732 $59.9 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $4.44 Million - $4.98 Million	-26,716 Reduced 8.29%	295,695 $54.6 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $6.24 Million - $7.29 Million	-36,839 Reduced 10.25%	322,411 $55 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $615,745 - $687,976	3,648 Added 1.03%	359,250 $62.5 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $826,747 - $943,922	4,942 Added 1.41%	355,602 $66.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	350,660	350,660 $60.5 Million

Others Institutions Holding AMGN

# of Institutions

3,120

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Account